These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31317573)
21. Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study. Pelli A; Junttila MJ; Kenttä TV; Schlögl S; Zabel M; Malik M; Reichlin T; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV; Europace; 2022 May; 24(5):774-783. PubMed ID: 34849744 [TBL] [Abstract][Full Text] [Related]
22. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043 [TBL] [Abstract][Full Text] [Related]
23. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799 [TBL] [Abstract][Full Text] [Related]
24. Left Atrial Function Using Cardiovascular Magnetic Resonance Imaging Independently Predicts Life-Threatening Arrhythmias in Patients Referred to Receive a Primary Prevention Implantable Cardioverter Defibrillator. Lydell CP; Mikami Y; Homer K; Peng M; Cornhill A; Rajagopalan A; Arasaratnam P; Cowan K; Roberts A; Sumner C; Heydari B; Howarth AG; Exner D; White JA Can J Cardiol; 2019 Sep; 35(9):1149-1157. PubMed ID: 31472813 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis. Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177 [TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
27. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Nombela-Franco L; Mitroi CD; Fernández-Lozano I; García-Touchard A; Toquero J; Castro-Urda V; Fernández-Diaz JA; Perez-Pereira E; Beltrán-Correas P; Segovia J; Werner GS; Javier G; Luis AP Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):147-54. PubMed ID: 22205684 [TBL] [Abstract][Full Text] [Related]
28. Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial. Zhang S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Lexcen DR; Muckala K; Brown ML; Cheng A; Singh B; Heart Rhythm; 2020 Mar; 17(3):468-475. PubMed ID: 31561030 [TBL] [Abstract][Full Text] [Related]
29. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients. Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247 [TBL] [Abstract][Full Text] [Related]
30. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry. Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040 [TBL] [Abstract][Full Text] [Related]
31. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]
32. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults. Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830 [TBL] [Abstract][Full Text] [Related]